Edita Čapkauskaitė

Edita Čapkauskaitė

Auto-generated profile, based on publicly available information

Edita Čapkauskaitė

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Vilnius University, Graiciuno 8, Vilnius LT-02241, Lithuania

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2013 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
Asta ZubrieneAsta Zubriene
Asta Zubriene
EČEdita Čapkauskaitė
Edita Čapkauskaitė
JGJoana Gylytė
Joana Gylytė
MKMiglė Kišonaitė
Miglė Kišonaitė
STSigitas Tumkevičius
Sigitas Tumkevičius
DMDaumantas Matulis
Daumantas Matulis
A series of benzenesulfonamide derivatives, bearing benzimidazole moieties, were designed and synthesized as inhibitors of carbonic anhydrases (CAs). Their binding affinities to recombinant human CA isozymes I, II, VII, XII and XIII were determined by the thermal shift assay. A group of compounds containing a benzimidazole substituent in the para position of the benzenesulfonamide ring was found to exhibit higher binding potency toward tested CAs than meta-substituted benzenesulfonamides. Some of these compounds exhibited nanomolar affinities and selectivity toward the CA isozymes tested.

28 October 2014 in Molecules
Verified
Journal Article
Open access
PDF file
KRKęstutis Rutkauskas
Kęstutis Rutkauskas
Asta ZubrieneAsta Zubriene
Asta Zubriene
ITIngrida Tumosienė
Ingrida Tumosienė
KKKristina Kantminienė
Kristina Kantminienė
MKMarytė Kažemėkaitė
Marytė Kažemėkaitė
DMDaumantas Matulis
Daumantas Matulis
A series of N-aryl-β-alanine derivatives and diazobenzenesulfonamides containing aliphatic rings were designed, synthesized, and their binding to carbonic anhydrases (CA) I, II, VI, VII, XII, and XIII was studied by the fluorescent thermal shift assay and isothermal titration calorimetry. The results showed that 4-substituted diazobenzenesulfonamides were more potent CA binders than N-aryl-β-alanine derivatives. Most of the N-aryl-β-alanine derivatives showed better affinity for CA II while diazobenzenesulfonamides possessed nanomolar affinities towards CA I isozyme. X-ray crystallographic structures showed the modes of binding of both compound groups.